Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study
Bilgin, Burak, Sendur, Mehmet Ali Nahit, Yucel, Sebnem, Celik, Emir, Ozyukseler, Deniz Tataroglu, Ayhan, Murat, Basoglu, Tugba, Ilhan, Aysegul, Akdeniz, Nadiye, Gulmez, Ahmet, Dogan, Izzet, Aktas, Burak Yasin, Gurbuz, Mustafa, Koca, Sinan, Paydas, Semra, Tatli, Ali Murat, Cinkir, Havva Yesil, Alan, Ozkan, Erol, Cihan, Hizal, Mutlu, Kut, Engin, Menevse, Serkan, Sakalar, Teoman, Taskaynatan, Halil, Deniz, Gulhan Ipek, Karaagac, Mustafa, Avci, Okan, Sen, Erdem, Karatas, Fatih, Akinci, Muhammed Bulent, Dede, Didem Sener, Demir, Atakan, Demirkazık, Ahmet, Oksuzoglu, Berna, Kilickap, Sadettin, Yumuk, Fulden, Yalcin, Bulent
Published in Journal of cancer research and clinical oncology (01.07.2021)
Published in Journal of cancer research and clinical oncology (01.07.2021)
Get full text
Journal Article